Strategies to optimize medication use in the physician group practice: The role of the clinical pharmacist

Journal of the American Pharmacists Association

Volumn 49, Issue 2, 2009, Pages 181-191

  Devine, Emily Beth ^a   Hoang, Susan ^b   Fisk, Albert W ^c   Wilson Norton, Jennifer L ^c   Lawless, Nathan M ^c   Louie, Clifton ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Developmental Therapeutics Committee and Co Chair of the Genitourinary Committee   (United States)

^c The Everett Clinic   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cost containment; Medication use; Pharmacists; Physicians; Quality of care; Strategic planning

Indexed keywords

DRUG; GENERIC DRUG;

ARTICLE; ECONOMICS; GROUP PRACTICE; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPITAL PHARMACY; PHARMACIST; PROFESSIONAL STANDARD; STANDARD; UNITED STATES;

DRUGS, GENERIC; GROUP PRACTICE; HEALTH CARE COSTS; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 67449107440     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2009.08009     Document Type: Article

References (43)

1. Health Care Costs 101. California HealthCare Foundation: 2007. Accessed at www.chcf.org/documents/insurance/HealthCare-Costs07.pdf, January 17, 2008.
2. Koch AL. Financing health services. In: Williams SJ, Torrens PR, Eds. Introduction to health services. 6th ed. Albany, NY: Delmar Thomson Learning; 2002:92-123.
3. Torrens PR, Williams SJ. Managed care: restructuring the system. In: Williams SJ, Torrens PR, Eds. Introduction to health services. 6th ed. Albany, NY: Delmar Thomson Learning; 2002:124-39.
4. Bodenheimer TS, Grumbach K. Capitation payment in managed care. In: Understanding health policy: a clinical approach. 3rd ed. New York: McGraw-Hill; 2002:33-52.
5. Cooper PF, Simon KI, Vistnes J. A closer look at the managed care backlash. Med Care. 2006;44(5 suppl):I4-11.
6. Kaiser Family Foundation. Trends and indicators in the changing health care marketplace. Accessed at www.kff.org/insurance/7031/print-sec1.cfm, January 17, 2008.
7. Kaiser Family Foundation. Survey of employer health benefits: 2007. Accessed at www.kff.org/insurance/7672/upload/7693.pdf, January 17, 2008.
8. Rosenthal MB, Landon BE, Normand ST, et al. Pay for performance in commercial HMOs. N Engl J Med. 2006;355:1895-902.
9. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635-45.
10. Kaiser Family Foundation. Prescription drug trends fact sheet: 2007. Accessed at www.kff.org/rxdrugs/upload/3057-06.pdf, January 17, 2008.
11. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192-9.
12. Hoffman JM, Shah ND, Vermeulen LC, et al. Projecting future drug expenditures: 2008. Am J Health Syst Pharm. 2008;65:234-53.
13. Medco. Drug trend report: humanomics. Accessed at https://host1. medcohealth.com/art/pdf/Drug-Trend-2007.pdf, January 17, 2008.
14. Accreditation Council for Pharmacy Education. Accreditation standards and guidelines: professional degree program. Accessed at www.acpe-accredit.org/ standards/default.asp, January 17, 2008.
15. Borgsdorf LR, Miano JS, Knapp KK. Pharmacist-managed medication review in a managed care system. Am J Hosp Pharm. 1991;48:265-70.
16. Gericke K, Louie C. Formulary management by an on-site school of pharmacy faculty member in a Medicaid managed care organization. J Manag Care Pharm. 1998;4:407-10.
17. Wilson-Norton JL, Fisk AW, Lawless NM. Managing prescribing cost and quality: one group's experience. Group Pract J. 2002;Oct:11-8.
18. Nau DP, Chi C, Mallya U, Kirking DM. Member satisfaction related to self-reported cost share and difficulty in obtaining prescription drugs in a university pharmacy benefit plan. J Manag Care Pharm. 2007;13:135-41.
19. Centers for Medicare & Medicaid Services. Medicare "pay for performance (P4P)" initiatives. Accessed at www.cms.hhs.gov/apps/media/ press/release.asp?Counter=1343, January 17, 2008.
20. Guyatt G, Rennie D, Eds. Users' guides to the medical literature: essentials of evidence-based clinical practice: the Evidencebased Medicine Working Group. Chicago: American Medical Association; 2002.
21. Academy of Managed Care Pharmacy. Therapeutic interchange: revised. Accessed at www.amcp.org/amcp.ark?c=legislative&sc=position&id=18, January 17, 2008.
22. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach: a randomized controlled trial of academically based "detailing." N Engl J Med. 1983;308:1457-63.
23. Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental designs for generalized causal inference. New York: Houghton Mifflin; 2002.
24. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med. 2005;142:891-7.
25. Sheffer J. Third class of drugs may be on the horizon. Accessed at www.pharmacist.com/AM/Template.cfm?Section=Pharmacy-Today2&template=/CM/ HTMLDisplay.cfm&ContentID=10620, March 25, 2008.
26. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72.
27. Centers for Disease Control and Prevention. Chronic disease overview. Accessed at www.cdc.gov/nccdphp/overview.htm, March 17, 2008.
28. Coleman EA, Brenson RA. Lost in transition: challenges and opportunities for improving the quality of transitional care. Ann Intern Med. 2004;140:533-6.
29. Devine EB, Wilson-Norton JL, Lawless NM, et al. Preparing for computerized prescriber order entry by evaluating preimplementation medication errors. In: Henriksen K, Battles JB, Mark ES, Lewin DI, eds. Advances in patient safety: from research to implementation. Vol. 2. Concepts and methodology. AHRQ publ. no. 05-0021-2. Rockville, MD: Agency for Healthcare Research and Quality; 2005.
30. Devine EB, Wilson-Norton JL, Lawless NM, et al. Characterization of prescribing errors in an internal medicine clinic. Am J Health Syst Pharm. 2007;64:1062-70.
31. Hollingworth W, Devine EB, Hansen RN, et al. The impact of e-prescribing on prescriber and staff time in ambulatory care clinics: a time-motion study. J Am Med Inform Assoc. 2007;14:722-30.
32. Chisholm MA, DiPiro JT. Pharmaceutical manufacturer assistance programs. Arch Intern Med. 2002;162:780-4.
33. Sarrafizadeh M, Waite NM, Hobson EH, Migden H. Pharmacist-facilitated enrollment in medication assistance programs in a private ambulatory care clinic. Am J Health Syst Pharm. 2004;61:1816-20.
34. Puget Sound Health Alliance. About the Puget Sound Health Alliance. Accessed at www.pugetsoundhealthalliance.org/about/index.html, March 25, 2008.
35. Puget Sound Health Alliance. Community checkup. Accessed at www.wacommunitycheckup.org, March 25, 2008.
36. Fischer MA, Avorn J. Economic implications of evidencebased prescribing for hypertension: can better care cost less? JAMA. 2004;291:1850-6.
37. National Committee for Quality Assurance. HEDIS 2007 measures. Accessed at http://web.ncqa.org/tabid/176/Default.aspx, January 17, 2008.
38. Cutler TW, Palmieri J, Khalsa M, Stebbins M. Evaluation of the relationship between a chronic disease care management program and California Pay-for-Performance diabetes care cholesterol measures in one medical group. J Manag Care Pharm. 2007;13:578-88.
39. Pharmacy Week. Fall 2007 Pharmacy compensation survey: national results. Accessed at www.pharmacyweek.com/job-seeker/salary/?e=404, January 17, 2008.
40. Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacists: 2003. Pharmacotherapy. 2003;23:1210-25.
41. National Association of Chain Drug Stores. Facts & resources: industry facts-at-a-glance. Accessed at www.nacds.org/wmspage.cfm?parm1=507, January 17, 2008.
42. Novartis Pharmaceuticals. Facts & figures: pharmacy benefit report. 2006 ed. East Hanover, NJ: Novartis Pharmaceuticals; 2006.
43. Thomson PDR. Drug topics red book. 2007 ed. Montvale, NJ: Thomson PDR; 2007.